Table 5.

Antiviral compounds from bacteria.

Name of the compound	Organisms	Active against	References
Sulfangolid C, soraphen F, epothilon D, and spirangien B, and Kulkenon	Sorangium cellulosum	HIV	Zander et al. (2012)
Rhizopodin	Myxococcus stipitatus	HIV	Martinez et al. (2013)
Thiangazole, phenalamide A1, and phenoxan	Polyangium species	HIV	Jurkiewicz et al. (1992)
Aetheramide A and aetheramide B (10b)	Aetherobacter	HIV	Trowitzsch-Kienast et al. (1992)
Ratjadon A (11) and α-pyrone	Sorangium cellulosum	HIV	Gerth et al. (1995)
Myxochelins A-F	Angiococcus disciformis	Human cytomegalovirus	Miyanaga et al. (2009)
Nannochelin A-C	Nannocystis exedens	Human cytomegalovirus	Kunze et al. (1992)
Hyalachelin A-C	Hyalangium minutum	Human cytomegalovirus	Nadmid et al. (2014)
Chondramide A-D	genus Chondromyces	EVD	Reichenbach (1988)
Noricumazol A-C	Sorangium cellulosum	EVD	Kunze et al. (1991)
Labindole A and B, 3-chloro-9H-carbazole, 4-hydroxymethyl-quinoline, and Soraphen A	Labilithrix luteola	HCV	Mulwa et al. (2018)
Lanyamycin	Sorangium cellulosum	HCV	Gentzsch et al. (2011)
Surfactin	Bacillus amyloliquefaciens	Antiviral activity	Koumoutsi et al. (2004)
Bacitracin	Bacillus licheniformis	Antiviral activity	Konz et al. (1997)
Lichenysin	Bacillus licheniformis	Antiviral activity	Veith et al. (2004)
Locillomycin	Bacillus subtilis1	Antiviral activity	Luo et al. (2015)
Macrolactin A	B. subtilis	HSV	Gustafson et al. (1989)
Exopolysaccharides (EPSs)	Pediococcus, Leuconostoc, Lactobacillus	Human adenovirus	Liubov et al. (2019)